The antibiotic subscription model: fostering innovation or repackaging old drugs?

Rebecca E. Glover
, Andrew C. Singer
, Adam Roberts
, Claas Kirchhelle

Tropical Disease Biology

Research output: Contribution to journal › Comment/debate

15 Citations (Scopus)

Original language	English
Pages (from-to)	e2-e3
Journal	The Lancet Microbe
Volume	4
Issue number	1
DOIs	https://doi.org/10.1016/s2666-5247(22)00235-x
Publication status	Published - 22 Sept 2022

Access to Document

10.1016/s2666-5247(22)00235-xLicence: CC BY-NC-ND

PIIS266652472200235XFinal published version, 43.2 KBLicence: CC BY-NC-ND

Cite this

@article{f1bde5b498a147d5ba10ba6d79559cf8,

title = "The antibiotic subscription model: fostering innovation or repackaging old drugs?",

author = "Glover, \{Rebecca E.\} and Singer, \{Andrew C.\} and Adam Roberts and Claas Kirchhelle",

year = "2022",

month = sep,

day = "22",

doi = "10.1016/s2666-5247(22)00235-x",

language = "English",

volume = "4",

pages = "e2--e3",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd",

number = "1",

}

TY - JOUR

T1 - The antibiotic subscription model: fostering innovation or repackaging old drugs?

AU - Glover, Rebecca E.

AU - Singer, Andrew C.

AU - Roberts, Adam

AU - Kirchhelle, Claas

PY - 2022/9/22

Y1 - 2022/9/22

U2 - 10.1016/s2666-5247(22)00235-x

DO - 10.1016/s2666-5247(22)00235-x

M3 - Comment/debate

SN - 2666-5247

VL - 4

SP - e2-e3

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 1

ER -